CERUS CORP Cost of Revenue
CERUS CORP (CERS) reported Cost of Revenue of $5.56 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2015-11-06
- CERUS CORP cost of revenue for the quarter ending 2015-09-30 was $5.56M, a 2.27% decline year-over-year.
- CERUS CORP cost of revenue for the quarter ending 2014-09-30 was $5.69M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 9 month |
|---|---|---|
| 2015-09-30 | $5.56M 10-Q · filed 2015-11-06 | $17.30M 10-Q · filed 2015-11-06 |
| 2014-09-30 | $5.69M 10-Q · filed 2015-11-06 | $14.60M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |